Heparin modification of a biomimetic bone matrix modulates osteogenic and angiogenic cell response in vitro
Mandy Quade(University Hospital Carl Gustav Carus), Anja Lode(University Hospital Carl Gustav Carus), Ulla König(Max Bergmann Zentrum für Biomaterialien), Angela Rösen‐Wolff(University Hospital Carl Gustav Carus), Dominik Weber(German Cancer Research Center), Paul Simon(Max Planck Institute for Chemical Physics of Solids), Birgit Paul(TU Dresden), Reinhard Schwartz‐Albiez(German Cancer Research Center), Sven Knaack(University Hospital Carl Gustav Carus), Michael Gelinsky(University Hospital Carl Gustav Carus)
Cited by 30
Related Papers
3D printing of hydrogels: Rational design strategies and emerging biomedical applications
|Materials Science and Engineering R Reports|2020|828
A definition of bioinks and their distinction from biomaterial inks
|Biofabrication|2018|774
Functionally graded materials for biomedical applications
|Materials Science and Engineering A|2003|570
Mobile Applications for Diabetics: A Systematic Review and Expert-Based Usability Evaluation Considering the Special Requirements of Diabetes Patients Age 50 Years or Older
|Journal of Medical Internet Research|2014|454
Tailoring Materials for Modulation of Macrophage Fate
|Advanced Materials|2021|400